Gene/environment interaction in atherosclerosis: An example of clinical medicine as seen from the evolutionary perspective

International Journal of Hypertension

Volumn 2010, Issue , 2010, Pages

  Mertens, Gerhard ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; LIPOPROTEIN;

ALLELE; APO E GENE; ATHEROSCLEROSIS; CHLAMYDOPHILA PNEUMONIAE; CLINICAL MEDICINE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; EVIDENCE BASED MEDICINE; EVOLUTION; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; LIPOPROTEIN METABOLISM; MEDICAL EDUCATION; NATURAL SELECTION; PASSIVE SMOKING; PATHOGENESIS; POPULATION GENETICS; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; REVIEW; SMOKING;

EID: 84868293626     PISSN: 20900384     EISSN: 20900392     Source Type: Journal    
DOI: 10.4061/2010/654078     Document Type: Review

References (19)

1. Dobzhansky T., Nothing in biology makes sense except in the light of evolution. American Biology Teacher 1973 35 125 129
2. Nesse R. M., nesse@umich.edu What evolutionary biology offers public health. Bulletin of the World Health Organization 2008 86 2 83 2-s2.0-31944443636 10.2471/BLT.07.049601 (Pubitemid 351213706)
3. Foy C. A., Grant P. J., Genes and the development of vascular disease. Postgraduate Medical Journal 1997 73 859 271 278 2-s2.0-0030949093 (Pubitemid 27248441)
4. Davignon J., Gregg R. E., Sing C. F., Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988 8 1 1 21 2-s2.0-0023860891 (Pubitemid 18049171)
5. Eichner J. E., Dunn S. T., Perveen G., Thompson D. M., Stewart K. E., Stroehla B. C., Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. American Journal of Epidemiology 2002 155 6 487 495 10.1093/aje/155.6.487 2-s2.0-0037087052 (Pubitemid 34208040)
6. Corbo R. M., Scacchi R., Apolipoprotein E (APOE) allele distribution in the world. Is APOE* 4 a 'thrifty' allele? Annals of Human Genetics 1999 63 4 301 310 10.1017/S0003480099007575 2-s2.0-0033398004 (Pubitemid 30021229)
7. Mahley R. W., rmahley@gladstone.ucsf.edu Rall S. C. Jr., Is ε 4 the ancestral human apoE allele? Neurobiology of Aging 1999 20 4 429 430 2-s2.0-0032839621 10.1016/S0197-4580(99)00081-0
8. Ströhle A., alexander.stroehle@gmx.de Wolters M., Hahn A., Human nutrition in the context of evolutionary medicine. Wiener Klinische Wochenschrift 2009 121 5-6 173 187 2-s2.0-65549127357 10.1007/s00508-009-1139-1
9. Maitland-van der Zee A.-H., Klungel O. H., Stricker B. H. Ch., Genetic polymorphisms: importance for response to HMG-CoA reductase inhibitors. Atherosclerosis 2002 163 2 213 222 10.1016/S0021-9150(01)00725-0 2-s2.0-0036277206 (Pubitemid 34615811)
10. Zak I., biogen@slam.katowice.pl Niemiec P., Balcerzyk A., Krauze J., Combined "pro-atherosclerotic" variants of the ACE and APOE genes increase the risk of the coronary artery disease associated with the presence of cigarette smoking. Acta Cardiologica 2008 63 6 741 747 2-s2.0-34547555885 10.2143/AC.63.6.2033392
11. Watson C., Alp N. J., Role of Chlamydia pneumoniae in atherosclerosis. Clinical Science 2008 114 7-8 509 531 10.1042/CS20070298 2-s2.0-41949084224 (Pubitemid 351548759)
12. Sessa R., Nicoletti M., Di Pietro M., Chlamydia pneumoniae and atherosclerosis: current state and future prospectives. International Journal of Immunopathology and Pharmacology 2009 22 1 9 14 2-s2.0-62649083251
13. Moazed T. C., Kuo C.-C., Grayston J. T., Campbell L. A., Murine models of Chlamydia pneumoniae infection and atherosclerosis. Journal of Infectious Diseases 1997 175 4 883 890 2-s2.0-0030940034 (Pubitemid 27142963)
14. Ewald P. W., pwewald@amherst.edu Cochran G. M., Chlamydia pneumoniae and cardiovascular disease: an evolutionary perspective on infectious causation and antibiotic treatment. Journal of Infectious Diseases 2000 181 supplement 3 S394 S401 2-s2.0-0031667721 (Pubitemid 30416104)
15. Hoymans V. Y., Bosmans J. M., Ieven M. M., Vrints C. J., Chlamydia pneumoniae-based atherosclerosis: a smoking gun. Acta Cardiologica 2007 62 6 565 571 10.2143/AC.62.6.2024015 2-s2.0-37049005170 (Pubitemid 350250543)
16. Barnoya J., Glantz S. A., Cardiovascular effects of secondhand smoke: nearly as large as smoking. Circulation 2005 111 20 2684 2698 10.1161/CIRCULATIONAHA.104.492215 2-s2.0-19644372377 (Pubitemid 40740869)
17. He J., Vupputuri S., Allen K., Prerost M. R., Hughes J., Whelton P. K., Passive smoking and the risk of coronary heart diseasea meta-analysis of epidemiologic studies. New England Journal of Medicine 1999 340 12 920 926 10.1056/NEJM199903253401204 2-s2.0-0033602551 (Pubitemid 29141053)
18. Whitman S. C., A practical approach to using mice in atherosclerosis research. The Clinical Biochemist Reviews 2004 25 81 93
19. Nesse R. M., Stearns S. C., Omenn G. S., Medicine needs evolution. Science 2006 311 5764 1071 2-s2.0-33644534203 10.1126/science.1125956